Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2004Cancer ResearchOpen Access

PD-L1/B7H-1 Inhibits the Effector Phase of Tumor Rejection by T Cell Receptor (TCR) Transgenic CD8+ T Cells

View Full Paper
Ask AI
Bookmark
Share

Authors

CBChristian U. BlankLeiden UniversityIBIan E. BrownUniversity of California, RiversideAPAmy PetersonRutgers, The State University of New Jersey

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Blank et al. (2004) studied this question.

synapsesocial.com/papers/6a11dbd9c031bb6829a57285https://doi.org/10.1158/0008-5472.can-03-3259
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice2001 · 1,885 citations
  2. 2PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells2003 · 627 citations
  3. 3Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone1996 · 199 citations
  4. 4Immune Inhibitory Receptors2000 · 1,292 citations
  5. 5Expression of Programmed Death 1 Ligands by Murine T Cells and APC2002 · 960 citations